nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—CYP1A2—chronic obstructive pulmonary disease	0.35	1	CbGaD
Dinoprostone—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.16	0.551	CbGbCtD
Dinoprostone—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0514	0.177	CbGbCtD
Dinoprostone—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0486	0.167	CbGbCtD
Dinoprostone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0304	0.105	CbGbCtD
Dinoprostone—PTGER4—pleura—chronic obstructive pulmonary disease	0.0283	0.272	CbGeAlD
Dinoprostone—PTGIR—pulmonary artery—chronic obstructive pulmonary disease	0.00998	0.0957	CbGeAlD
Dinoprostone—PTGER4—respiratory system—chronic obstructive pulmonary disease	0.00281	0.027	CbGeAlD
Dinoprostone—PTGER4—connective tissue—chronic obstructive pulmonary disease	0.00248	0.0238	CbGeAlD
Dinoprostone—PTGER3—respiratory system—chronic obstructive pulmonary disease	0.00238	0.0229	CbGeAlD
Dinoprostone—PTGER4—bronchus—chronic obstructive pulmonary disease	0.00232	0.0222	CbGeAlD
Dinoprostone—SLC51A—bronchus—chronic obstructive pulmonary disease	0.00228	0.0218	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—chronic obstructive pulmonary disease	0.00227	0.0217	CbGeAlD
Dinoprostone—PTGER2—trachea—chronic obstructive pulmonary disease	0.00212	0.0203	CbGeAlD
Dinoprostone—PTGER3—connective tissue—chronic obstructive pulmonary disease	0.0021	0.0201	CbGeAlD
Dinoprostone—HPGDS—respiratory system—chronic obstructive pulmonary disease	0.00206	0.0198	CbGeAlD
Dinoprostone—SLC51B—lung—chronic obstructive pulmonary disease	0.00205	0.0196	CbGeAlD
Dinoprostone—SLC51A—trachea—chronic obstructive pulmonary disease	0.00204	0.0196	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00192	0.0184	CbGeAlD
Dinoprostone—PTGFR—respiratory system—chronic obstructive pulmonary disease	0.00191	0.0183	CbGeAlD
Dinoprostone—HPGDS—connective tissue—chronic obstructive pulmonary disease	0.00181	0.0174	CbGeAlD
Dinoprostone—PTGIR—respiratory system—chronic obstructive pulmonary disease	0.00168	0.0161	CbGeAlD
Dinoprostone—PTGFR—bronchus—chronic obstructive pulmonary disease	0.00157	0.015	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00153	0.0147	CbGeAlD
Dinoprostone—PTGER2—lung—chronic obstructive pulmonary disease	0.00152	0.0146	CbGeAlD
Dinoprostone—PTGER4—lung—chronic obstructive pulmonary disease	0.00149	0.0143	CbGeAlD
Dinoprostone—PTGIR—connective tissue—chronic obstructive pulmonary disease	0.00148	0.0142	CbGeAlD
Dinoprostone—SLC51A—lung—chronic obstructive pulmonary disease	0.00147	0.0141	CbGeAlD
Dinoprostone—SLCO2A1—respiratory system—chronic obstructive pulmonary disease	0.00147	0.0141	CbGeAlD
Dinoprostone—PTGFR—trachea—chronic obstructive pulmonary disease	0.00141	0.0135	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00135	0.013	CbGeAlD
Dinoprostone—CYP11A1—connective tissue—chronic obstructive pulmonary disease	0.00128	0.0123	CbGeAlD
Dinoprostone—PTGER3—lung—chronic obstructive pulmonary disease	0.00127	0.0121	CbGeAlD
Dinoprostone—SLCO3A1—bronchus—chronic obstructive pulmonary disease	0.00122	0.0117	CbGeAlD
Dinoprostone—SLCO2A1—bronchus—chronic obstructive pulmonary disease	0.00121	0.0116	CbGeAlD
Dinoprostone—SLCO4A1—bronchus—chronic obstructive pulmonary disease	0.00111	0.0107	CbGeAlD
Dinoprostone—ABCC5—bronchus—chronic obstructive pulmonary disease	0.0011	0.0106	CbGeAlD
Dinoprostone—HPGDS—lung—chronic obstructive pulmonary disease	0.00109	0.0105	CbGeAlD
Dinoprostone—SLCO2A1—trachea—chronic obstructive pulmonary disease	0.00108	0.0104	CbGeAlD
Dinoprostone—SLCO2B1—respiratory system—chronic obstructive pulmonary disease	0.00105	0.0101	CbGeAlD
Dinoprostone—PTGFR—lung—chronic obstructive pulmonary disease	0.00101	0.0097	CbGeAlD
Dinoprostone—SLCO4A1—trachea—chronic obstructive pulmonary disease	0.000998	0.00957	CbGeAlD
Dinoprostone—PTGIR—lung—chronic obstructive pulmonary disease	0.000892	0.00855	CbGeAlD
Dinoprostone—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.000831	0.00797	CbGeAlD
Dinoprostone—SLCO3A1—lung—chronic obstructive pulmonary disease	0.000787	0.00755	CbGeAlD
Dinoprostone—SLCO2A1—lung—chronic obstructive pulmonary disease	0.000779	0.00747	CbGeAlD
Dinoprostone—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000766	0.00734	CbGeAlD
Dinoprostone—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.000732	0.00545	CcSEcCtD
Dinoprostone—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.00545	CcSEcCtD
Dinoprostone—SLCO4A1—lung—chronic obstructive pulmonary disease	0.000717	0.00688	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000717	0.00534	CcSEcCtD
Dinoprostone—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00534	CcSEcCtD
Dinoprostone—ABCC5—lung—chronic obstructive pulmonary disease	0.000713	0.00684	CbGeAlD
Dinoprostone—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000702	0.00523	CcSEcCtD
Dinoprostone—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000702	0.00523	CcSEcCtD
Dinoprostone—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00515	CcSEcCtD
Dinoprostone—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00515	CcSEcCtD
Dinoprostone—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000691	0.00515	CcSEcCtD
Dinoprostone—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000691	0.00515	CcSEcCtD
Dinoprostone—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000688	0.00513	CcSEcCtD
Dinoprostone—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00511	CcSEcCtD
Dinoprostone—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000663	0.00494	CcSEcCtD
Dinoprostone—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00066	0.00492	CcSEcCtD
Dinoprostone—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00486	CcSEcCtD
Dinoprostone—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00481	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000643	0.0048	CcSEcCtD
Dinoprostone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000632	0.00606	CbGeAlD
Dinoprostone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00471	CcSEcCtD
Dinoprostone—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000631	0.0047	CcSEcCtD
Dinoprostone—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00469	CcSEcCtD
Dinoprostone—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000622	0.00464	CcSEcCtD
Dinoprostone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000622	0.00464	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000617	0.0046	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.0046	CcSEcCtD
Dinoprostone—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00457	CcSEcCtD
Dinoprostone—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00457	CcSEcCtD
Dinoprostone—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.000606	0.00452	CcSEcCtD
Dinoprostone—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000602	0.00449	CcSEcCtD
Dinoprostone—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00437	CcSEcCtD
Dinoprostone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00058	0.00432	CcSEcCtD
Dinoprostone—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00426	CcSEcCtD
Dinoprostone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000564	0.00421	CcSEcCtD
Dinoprostone—SLCO2B1—lung—chronic obstructive pulmonary disease	0.000558	0.00535	CbGeAlD
Dinoprostone—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00416	CcSEcCtD
Dinoprostone—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00416	CcSEcCtD
Dinoprostone—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00407	CcSEcCtD
Dinoprostone—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00405	CcSEcCtD
Dinoprostone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000538	0.00401	CcSEcCtD
Dinoprostone—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00397	CcSEcCtD
Dinoprostone—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000529	0.00394	CcSEcCtD
Dinoprostone—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00393	CcSEcCtD
Dinoprostone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000525	0.00391	CcSEcCtD
Dinoprostone—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.0039	CcSEcCtD
Dinoprostone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00052	0.00388	CcSEcCtD
Dinoprostone—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Dinoprostone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Dinoprostone—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Dinoprostone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Dinoprostone—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000513	0.00492	CbGeAlD
Dinoprostone—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00382	CcSEcCtD
Dinoprostone—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00378	CcSEcCtD
Dinoprostone—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00378	CcSEcCtD
Dinoprostone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00374	CcSEcCtD
Dinoprostone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00374	CcSEcCtD
Dinoprostone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0005	0.00373	CcSEcCtD
Dinoprostone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00371	CcSEcCtD
Dinoprostone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.0037	CcSEcCtD
Dinoprostone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.00369	CcSEcCtD
Dinoprostone—ABCC4—lung—chronic obstructive pulmonary disease	0.000494	0.00474	CbGeAlD
Dinoprostone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000493	0.00367	CcSEcCtD
Dinoprostone—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00367	CcSEcCtD
Dinoprostone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00365	CcSEcCtD
Dinoprostone—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00363	CcSEcCtD
Dinoprostone—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.0036	CcSEcCtD
Dinoprostone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00359	CcSEcCtD
Dinoprostone—Tension—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00358	CcSEcCtD
Dinoprostone—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00358	CcSEcCtD
Dinoprostone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00357	CcSEcCtD
Dinoprostone—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00355	CcSEcCtD
Dinoprostone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00353	CcSEcCtD
Dinoprostone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00353	CcSEcCtD
Dinoprostone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00353	CcSEcCtD
Dinoprostone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00351	CcSEcCtD
Dinoprostone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00351	CcSEcCtD
Dinoprostone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000467	0.00348	CcSEcCtD
Dinoprostone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00343	CcSEcCtD
Dinoprostone—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00342	CcSEcCtD
Dinoprostone—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00342	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000455	0.00339	CcSEcCtD
Dinoprostone—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00338	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00336	CcSEcCtD
Dinoprostone—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00335	CcSEcCtD
Dinoprostone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00333	CcSEcCtD
Dinoprostone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00331	CcSEcCtD
Dinoprostone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00331	CcSEcCtD
Dinoprostone—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00044	0.00328	CcSEcCtD
Dinoprostone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00323	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000429	0.0032	CcSEcCtD
Dinoprostone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00318	CcSEcCtD
Dinoprostone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00318	CcSEcCtD
Dinoprostone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00315	CcSEcCtD
Dinoprostone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00315	CcSEcCtD
Dinoprostone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.00312	CcSEcCtD
Dinoprostone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00312	CcSEcCtD
Dinoprostone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.0031	CcSEcCtD
Dinoprostone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000415	0.00309	CcSEcCtD
Dinoprostone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000415	0.00309	CcSEcCtD
Dinoprostone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00309	CcSEcCtD
Dinoprostone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00304	CcSEcCtD
Dinoprostone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00304	CcSEcCtD
Dinoprostone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00303	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00302	CcSEcCtD
Dinoprostone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.003	CcSEcCtD
Dinoprostone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00298	CcSEcCtD
Dinoprostone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00298	CcSEcCtD
Dinoprostone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00297	CcSEcCtD
Dinoprostone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00293	CcSEcCtD
Dinoprostone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00293	CcSEcCtD
Dinoprostone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00293	CcSEcCtD
Dinoprostone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000391	0.00292	CcSEcCtD
Dinoprostone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000391	0.00292	CcSEcCtD
Dinoprostone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.0029	CcSEcCtD
Dinoprostone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00039	0.0029	CcSEcCtD
Dinoprostone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00288	CcSEcCtD
Dinoprostone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00281	CcSEcCtD
Dinoprostone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00278	CcSEcCtD
Dinoprostone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00278	CcSEcCtD
Dinoprostone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00277	CcSEcCtD
Dinoprostone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00276	CcSEcCtD
Dinoprostone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00274	CcSEcCtD
Dinoprostone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00272	CcSEcCtD
Dinoprostone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00272	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00271	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00271	CcSEcCtD
Dinoprostone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00268	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00266	CcSEcCtD
Dinoprostone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00265	CcSEcCtD
Dinoprostone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00265	CcSEcCtD
Dinoprostone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00263	CcSEcCtD
Dinoprostone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00262	CcSEcCtD
Dinoprostone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000347	0.00259	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00256	CcSEcCtD
Dinoprostone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00255	CcSEcCtD
Dinoprostone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00255	CcSEcCtD
Dinoprostone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00252	CcSEcCtD
Dinoprostone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00251	CcSEcCtD
Dinoprostone—CYP1A2—lung—chronic obstructive pulmonary disease	0.000336	0.00322	CbGeAlD
Dinoprostone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00249	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00249	CcSEcCtD
Dinoprostone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00249	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00248	CcSEcCtD
Dinoprostone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00247	CcSEcCtD
Dinoprostone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00246	CcSEcCtD
Dinoprostone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.00245	CcSEcCtD
Dinoprostone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.00244	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00243	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00243	CcSEcCtD
Dinoprostone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.0024	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00238	CcSEcCtD
Dinoprostone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00235	CcSEcCtD
Dinoprostone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00235	CcSEcCtD
Dinoprostone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00235	CcSEcCtD
Dinoprostone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00235	CcSEcCtD
Dinoprostone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00234	CcSEcCtD
Dinoprostone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00233	CcSEcCtD
Dinoprostone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00232	CcSEcCtD
Dinoprostone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000312	0.00232	CcSEcCtD
Dinoprostone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00231	CcSEcCtD
Dinoprostone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000309	0.0023	CcSEcCtD
Dinoprostone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000309	0.0023	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.0023	CcSEcCtD
Dinoprostone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Dinoprostone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00222	CcSEcCtD
Dinoprostone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00222	CcSEcCtD
Dinoprostone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00219	CcSEcCtD
Dinoprostone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00219	CcSEcCtD
Dinoprostone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000294	0.00219	CcSEcCtD
Dinoprostone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00215	CcSEcCtD
Dinoprostone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00214	CcSEcCtD
Dinoprostone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00214	CcSEcCtD
Dinoprostone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00209	CcSEcCtD
Dinoprostone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00207	CcSEcCtD
Dinoprostone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00204	CcSEcCtD
Dinoprostone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00204	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00203	CcSEcCtD
Dinoprostone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00202	CcSEcCtD
Dinoprostone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00201	CcSEcCtD
Dinoprostone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00199	CcSEcCtD
Dinoprostone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00197	CcSEcCtD
Dinoprostone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00197	CcSEcCtD
Dinoprostone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00193	CcSEcCtD
Dinoprostone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00192	CcSEcCtD
Dinoprostone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00189	CcSEcCtD
Dinoprostone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00189	CcSEcCtD
Dinoprostone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00188	CcSEcCtD
Dinoprostone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00188	CcSEcCtD
Dinoprostone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00187	CcSEcCtD
Dinoprostone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00187	CcSEcCtD
Dinoprostone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00186	CcSEcCtD
Dinoprostone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00186	CcSEcCtD
Dinoprostone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00186	CcSEcCtD
Dinoprostone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00186	CcSEcCtD
Dinoprostone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00185	CcSEcCtD
Dinoprostone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00184	CcSEcCtD
Dinoprostone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00184	CcSEcCtD
Dinoprostone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00183	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00181	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000242	0.0018	CcSEcCtD
Dinoprostone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00179	CcSEcCtD
Dinoprostone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00177	CcSEcCtD
Dinoprostone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00177	CcSEcCtD
Dinoprostone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00177	CcSEcCtD
Dinoprostone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00177	CcSEcCtD
Dinoprostone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00177	CcSEcCtD
Dinoprostone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00176	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.00174	CcSEcCtD
Dinoprostone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00173	CcSEcCtD
Dinoprostone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00171	CcSEcCtD
Dinoprostone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00167	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00161	CcSEcCtD
Dinoprostone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00159	CcSEcCtD
Dinoprostone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00157	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00156	CcSEcCtD
Dinoprostone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00153	CcSEcCtD
Dinoprostone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000201	0.0015	CcSEcCtD
Dinoprostone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00149	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00147	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00145	CcSEcCtD
Dinoprostone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00138	CcSEcCtD
Dinoprostone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00135	CcSEcCtD
Dinoprostone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00129	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00126	CcSEcCtD
Dinoprostone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00124	CcSEcCtD
Dinoprostone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00122	CcSEcCtD
Dinoprostone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00122	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00119	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00117	CcSEcCtD
Dinoprostone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00115	CcSEcCtD
Dinoprostone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00114	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00113	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00107	CcSEcCtD
Dinoprostone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00107	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00105	CcSEcCtD
Dinoprostone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00102	CcSEcCtD
Dinoprostone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00102	CcSEcCtD
Dinoprostone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00101	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000958	CcSEcCtD
Dinoprostone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000957	CcSEcCtD
Dinoprostone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000926	CcSEcCtD
Dinoprostone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000926	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000863	CcSEcCtD
Dinoprostone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00084	CcSEcCtD
Dinoprostone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000801	CcSEcCtD
Dinoprostone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000775	CcSEcCtD
Dinoprostone—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000745	CcSEcCtD
Dinoprostone—Rash—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000739	CcSEcCtD
Dinoprostone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000738	CcSEcCtD
Dinoprostone—Headache—Prednisone—chronic obstructive pulmonary disease	9.84e-05	0.000734	CcSEcCtD
Dinoprostone—Nausea—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000696	CcSEcCtD
Dinoprostone—PTGER2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.39e-05	0.000279	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.39e-05	0.000278	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	3.37e-05	0.000277	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.36e-05	0.000276	CbGpPWpGaD
Dinoprostone—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.35e-05	0.000276	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.32e-05	0.000273	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.3e-05	0.000271	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.3e-05	0.000271	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.27e-05	0.000268	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.27e-05	0.000268	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.25e-05	0.000267	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.23e-05	0.000265	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.22e-05	0.000265	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.000264	CbGpPWpGaD
Dinoprostone—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.21e-05	0.000263	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.2e-05	0.000263	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.18e-05	0.000262	CbGpPWpGaD
Dinoprostone—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.17e-05	0.000261	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.17e-05	0.00026	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.15e-05	0.000259	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.15e-05	0.000259	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	3.14e-05	0.000258	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.13e-05	0.000257	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.13e-05	0.000257	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.1e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.08e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.05e-05	0.000251	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.05e-05	0.000251	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.04e-05	0.00025	CbGpPWpGaD
Dinoprostone—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.04e-05	0.00025	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.99e-05	0.000246	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.99e-05	0.000246	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000246	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.97e-05	0.000244	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.97e-05	0.000244	CbGpPWpGaD
Dinoprostone—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000243	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.95e-05	0.000243	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000242	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.94e-05	0.000242	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.000241	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.92e-05	0.00024	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—ALB—chronic obstructive pulmonary disease	2.9e-05	0.000238	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.89e-05	0.000237	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.88e-05	0.000236	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.86e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.85e-05	0.000234	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.84e-05	0.000233	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.000233	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.00023	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.78e-05	0.000228	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.78e-05	0.000228	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—NOS3—chronic obstructive pulmonary disease	2.77e-05	0.000228	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.000227	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.76e-05	0.000227	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000227	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.74e-05	0.000225	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.72e-05	0.000224	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000224	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.69e-05	0.000221	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.66e-05	0.000219	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.64e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.000215	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.57e-05	0.000211	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.56e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.56e-05	0.000211	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	2.56e-05	0.00021	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.55e-05	0.000209	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.54e-05	0.000208	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.52e-05	0.000207	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.5e-05	0.000206	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.5e-05	0.000205	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000202	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000194	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.35e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.000192	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.33e-05	0.000191	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.32e-05	0.000191	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.32e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.000188	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.000188	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.28e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.27e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—chronic obstructive pulmonary disease	2.24e-05	0.000184	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.23e-05	0.000184	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000183	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.22e-05	0.000182	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.21e-05	0.000182	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.19e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.17e-05	0.000178	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.16e-05	0.000178	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.14e-05	0.000176	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	2.13e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.13e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.12e-05	0.000174	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000174	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.12e-05	0.000174	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.1e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.08e-05	0.000171	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.08e-05	0.000171	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.00017	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.06e-05	0.000169	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.000168	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.04e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.02e-05	0.000166	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000165	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2e-05	0.000165	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2e-05	0.000165	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2e-05	0.000164	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000163	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.96e-05	0.000161	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.00016	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.93e-05	0.000159	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000159	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.9e-05	0.000156	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.86e-05	0.000153	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.86e-05	0.000153	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000152	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000151	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.83e-05	0.000151	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000149	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.81e-05	0.000149	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000149	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000148	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.77e-05	0.000145	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000145	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000145	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.74e-05	0.000143	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000141	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	1.71e-05	0.000141	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.69e-05	0.000139	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000137	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.66e-05	0.000137	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.66e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.63e-05	0.000134	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.63e-05	0.000134	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.63e-05	0.000134	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.62e-05	0.000133	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000133	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000132	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.61e-05	0.000132	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.000129	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000127	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.53e-05	0.000126	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000126	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.51e-05	0.000124	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.5e-05	0.000124	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	1.5e-05	0.000123	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.5e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.49e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.49e-05	0.000122	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.000121	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.47e-05	0.000121	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.46e-05	0.00012	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.46e-05	0.00012	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.000119	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.44e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000117	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000117	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.000117	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000115	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000115	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000114	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.37e-05	0.000113	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000113	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.37e-05	0.000113	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000112	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.37e-05	0.000112	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000111	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.34e-05	0.00011	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.34e-05	0.00011	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000108	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000105	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000105	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000105	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000104	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-05	0.000104	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000103	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.000103	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000103	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000102	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000102	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.24e-05	0.000102	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	9.96e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.2e-05	9.89e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	9.77e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	9.68e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	9.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	9.63e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	9.63e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.14e-05	9.41e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	1.13e-05	9.32e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.13e-05	9.25e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	9.21e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	9.21e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	1.11e-05	9.14e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	9.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	8.98e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	8.94e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.04e-05	8.53e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	8.51e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.03e-05	8.47e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.03e-05	8.45e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	8.27e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	8.27e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.64e-06	7.92e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.51e-06	7.81e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.43e-06	7.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.25e-06	7.6e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.23e-06	7.59e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.23e-06	7.59e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.22e-06	7.58e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.05e-06	7.44e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.05e-06	7.44e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.71e-06	7.16e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	8.54e-06	7.02e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.33e-06	6.85e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.24e-06	6.77e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.02e-06	6.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.93e-06	6.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.88e-06	6.48e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.77e-06	6.38e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.6e-06	6.25e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.6e-06	6.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	7.55e-06	6.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.4e-06	6.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.24e-06	5.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.22e-06	5.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.11e-06	5.84e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.04e-06	5.78e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.96e-06	5.72e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.96e-06	5.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.73e-06	5.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.56e-06	4.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.49e-06	4.51e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.11e-06	4.2e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.85e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-06	2.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-06	2.59e-05	CbGpPWpGaD
